1264.Two
1264.TWO operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.
Business. 1264.TWO operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
1264.TWO operates in the Food & Drug Retailing industry, generating revenue primarily through the sale of food and drug products to consumers.
1264.TWO maintains a strong liquidity position with a current ratio of 2.51, indicating the company can cover its short-term liabilities more than twice over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The price-to-book ratio of 2.74 suggests the market values the company at a premium to its book value, while the price-to-earnings ratio of 13.24 indicates a moderate valuation relative to earnings.
The company's profitability is robust, with a return on equity of 20.66% and a return on assets of 12.79%, both exceeding the typical thresholds for the Food Retail & Distribution industry. The operating margin, calculated as operating income of 1137.2 million TWD on revenue of 6.78 billion TWD, reflects a healthy margin of 16.8%, which is in line with industry expectations. The gross margin of 32.2% further supports the company's ability to maintain pricing power and control costs.
Geographically, 1264.TWO's revenue is concentrated in its domestic market, with no disclosed international segments. The company's business is not segmented by product lines in the latest financial data, but its primary activity is the retailing of food and drug products. This concentration may expose the company to regional economic fluctuations and regulatory changes.
Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year. The operating cash flow of 1.04 billion TWD and free cash flow of 169.6 million TWD support the company's ability to fund operations and reinvest in the business. The capital expenditure of -259.1 million TWD indicates a reduction in investment in physical assets, which may signal a shift in strategic focus or a response to market conditions.
The risk assessment for 1264.TWO highlights a medium liquidity risk due to the negative net cash position after debt. The dilution risk is low, with no significant dilution expected in the near term. The company's debt-to-equity ratio of 0.18 suggests a conservative capital structure, with limited leverage. However, the company's reliance on domestic markets and the absence of international diversification may increase its exposure to local economic and regulatory risks.
Recent filings and transcripts do not indicate any material events or strategic shifts for 1264.TWO. The company's financial performance and operational strategy appear to be stable, with no significant changes in management or business direction reported in the latest disclosures.
- 1264.TWO has a strong liquidity position with a current ratio of 2.51, but its net cash is negative after subtracting total debt.
- The company's profitability is robust, with a return on equity of 20.66% and a return on assets of 12.79%.
- 1264.TWO's revenue is concentrated in its domestic market, with no disclosed international segments.
- The company is projected to maintain a stable growth trajectory, with no significant changes in revenue expected in the next fiscal year.
- The risk assessment highlights a medium liquidity risk and a low dilution risk, with a conservative capital structure indicated by a debt-to-equity ratio of 0.18.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 1264.TWO Market data — financials · 2026-05-26